Online First

Current Management of Early Stage NSCLC

Trial Data: Early Stage Lung Cancer

Genomic and Immune Profiling

Presented By
Dr Ke-Zhong Chen, Peking University People’s Hospital, Beijing, China
Conference
ELCC 2019

Immunotherapy in Stage 4 Lung Cancer

Predictive Diagnostics for I-O

Presented By
Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain
Trial
Phase 3, BFAST
Conference
ELCC 2019

Trials: Immunotherapy in Stage 4 Lung Cancer

Implementation of Personalised Lung Cancer Care in Clinical Routine

Experiences from France

Presented By
Dr Benjamin Besse, Institut Gustave Roussy, France
Conference
ELCC 2019

Optimal Management of Brain Metastases in NSCLC

Brain Irradiation as Treatment Option

Presented By
Prof. Corinne Faivre-Finn, The Christie NHS Foundation Trust and University of Manchester, United Kingdom
Trial
Phase 3, QUARTZ
Conference
ELCC 2019

Small Cell Lung Cancer: New Targets

Immunotherapy in SCLC: Trial Data

Presented By
Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain
Trial
CA184-156, CheckMate-451, CASPIAN, Keynote-604, Checkmate 032
Conference
ELCC 2019